Popularity of Surgical and Pharmacological Obesity Treatment Methods Searched by Google Users: the Retrospective Analysis of Google Trends Statistics in 2004–2022

[11] Busetto L(2022)Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: an infodemiological study Front Cardiovasc Med 9 936651-4579

[12] Micic D(2014)The use of Google trends in health care research: a systematic review. Voracek M, editor PLoS ONE. 9 e109583-500

[13] Murtha JA(2022)Clinical outcomes of bariatric surgery - updated evidence Obes Res Clin Pract 16 1-291

[14] Alagoz E(2021)US national trends in bariatric surgery: A decade of study Surgery 170 13-917

[15] Breuer CR(2022)Obesity and bariatric surgery in Australia: future projection of supply and demand, and costs OBES SURG 32 3013-4

[16] Finn A(2016)Trends in bariatric surgery: procedure selection, revisional surgeries, and readmissions Obes Surg 26 1371-9

[17] Raffa SD(2019)New era: endoscopic treatment options in obesity-a paradigm shift World J Gastroenterol 25 4567-1247

[18] Voils CI(2018)US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity Int J Obes (Lond) 42 495-544

[19] Coulter AA(2001)Appetite suppressants and valvular heart disease Am J Med Sci 321 285-undefined

[20] Rebello CJ(2010)Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects N Engl J Med 363 905-undefined

[11] Busetto L(2022)Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: an infodemiological study Front Cardiovasc Med 9 936651-4579

[12] Micic D(2014)The use of Google trends in health care research: a systematic review. Voracek M, editor PLoS ONE. 9 e109583-500

[13] Murtha JA(2022)Clinical outcomes of bariatric surgery - updated evidence Obes Res Clin Pract 16 1-291

[14] Alagoz E(2021)US national trends in bariatric surgery: A decade of study Surgery 170 13-917

[15] Breuer CR(2022)Obesity and bariatric surgery in Australia: future projection of supply and demand, and costs OBES SURG 32 3013-4

[16] Finn A(2016)Trends in bariatric surgery: procedure selection, revisional surgeries, and readmissions Obes Surg 26 1371-9

[17] Raffa SD(2019)New era: endoscopic treatment options in obesity-a paradigm shift World J Gastroenterol 25 4567-1247

[18] Voils CI(2018)US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity Int J Obes (Lond) 42 495-544

[19] Coulter AA(2001)Appetite suppressants and valvular heart disease Am J Med Sci 321 285-undefined

[20] Rebello CJ(2010)Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects N Engl J Med 363 905-undefined